Overview
Primary small cell carcinoma of the lung (SCLC) is a highly aggressive neuroendocrine tumor. The majority of patients present with metastatic (extensive-stage) disease, which is more common than limited-stage disease 1. Systemic therapy is the cornerstone of treatment for extensive-stage SCLC, aiming to palliate symptoms and prolong survival 1.Diagnosis
Management
Key Recommendations
References
1 Ganti AKP, Loo BW, Bassetti M, Blakely C, Chiang A, D'Amico TA et al.. Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN 2021. link